Legal Issues for the Medical Director
Trulove WG. Clin J Am Soc Nephrol. 2014. Read more
Intradialytic hypotension and risk of cardiovascular disease
Stefansson BV, Brunelli SM, Cabrera C, et al. Clin J Am Soc Nephrol. 2014;9(12):2124-2132. Read more
Effects of Crit-Line(R) monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched study
Sibbel SP, Ficociello LH, Black M, et al. Blood Purif. 2014;37(3):249-257. Read more
For-profit dialysis providers
Nissenson AR. Health Aff (Millwood). 2014;33(11):2082. Read more
Improving outcomes for ESRD patients: shifting the quality paradigm
Nissenson AR. Clin J Am Soc Nephrol. 2014;9(2):430-434. Read more
New alternatives in anemia treatment: biosimilars and HIF stabilizers
Krishnan M, Nissenson AR. Nephrol News Issues. 2014;28(6):24-28. Read more
ESRD special needs plans: a proof of concept for integrated care
Krishnan M, Franco E, McMurray S, Petra E, Nissenson AR. Nephrol News Issues. 2014;28(12):30, 32, 34-36. Read more
To Eat or Not to Eat-International Experiences With Eating During Hemodialysis Treatment
Kistler B, Benner D, Burgess M, Stasios M, Kalantar-Zadeh K, Wilund KR. J Ren Nutr. 2014;24(6):349-352. Read more
Real-world dose-relativity, tablet burden, and cost comparison of conversion between sevelamer hydrochloride/carbonate and lanthanum carbonate monotherapies
Keith MS, Sibbel S, Copley JB, Wilson RJ, Brunelli SM. Clin Ther. 2014;36(10):1431-1442 e1431. Read more
Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation
Brunelli SM, Wilson S, Krishnan M, Nissenson AR. BMC Nephrol. 2014;15:121. Read more
x
x